Literature DB >> 27921194

Practical diagnostic criterion of blood stasis syndrome : Activating blood circulation committee of Chinese association of integrative medicine.

Hao Xu1, Ke-Ji Chen2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27921194     DOI： 10.1007/s11655-016-2400-x

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN： 1672-0415            Impact factor:   1.978


× No keyword cloud information.
  1 in total

1.  [Practical Diagnostic Criterion of Blood Stasis Syndrome: Introduction, Reliability, and Validity].

Authors:  Jing Luo; An-lu Wang; Wei Zhao; Fang-yuan Che; Qian Feng; Dan-hui Yi; Hao Xu; Ke-ji Chen
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  2015-08
  1 in total
  6 in total

1.  Application and Prospect of Platelet Multi-Omics Technology in Study of Blood Stasis Syndrome.

Authors:  Ying Li; Ming-Qian Sun; Lei Li; Ye-Hao Zhang; Lan Miao; Jian-Xun Liu
Journal:  Chin J Integr Med       Date:  2021-12-20       Impact factor: 1.978

2.  Identification of blood-activating components from Xueshuan Xinmaining Tablet based on the spectrum-effect relationship and network pharmacology analysis.

Authors:  Jing Tan; Junli Liu; Han Wang; Ying Zhang; Hongqiang Lin; Zhongyao Wang; Hanrui Si; Yutong Zhang; Jinping Liu; Pingya Li; Kai Sun
Journal:  RSC Adv       Date:  2020-03-10       Impact factor: 4.036

3.  Effect of diabetes blood-stasis syndrome and Xuefu Zhuyu decoction on ERK1/2-VEGF signal pathway in rat retina Müller cells.

Authors:  Xiaofeng Ye; Hui Ren; Tingting Jiang; Ting Zhang; Gang Li
Journal:  Histol Histopathol       Date:  2022-02-03       Impact factor: 2.130

4.  Comprehensive Metabolomics Analysis of Xueshuan Xinmaining Tablet in Blood Stasis Model Rats Using UPLC-Q/TOF-MS.

Authors:  Jing Tan; Cuizhu Wang; Hailin Zhu; Baisong Zhou; Lingxin Xiong; Fang Wang; Pingya Li; Jinping Liu
Journal:  Molecules       Date:  2018-07-06       Impact factor: 4.411

5.  Guanxinning tablet for patients who switch from dual antiplatelet therapy to aspirin alone after percutaneous coronary intervention: study protocol for a cluster randomized controlled trial.

Authors:  Jingen Li; Jianqing Ju; Zhuo Chen; Jing Liu; Fang Lu; Rui Gao; Hao Xu
Journal:  Trials       Date:  2018-02-07       Impact factor: 2.279

6.  The Enhanced Pharmacological Effects of Modified Traditional Chinese Medicine in Attenuation of Atherosclerosis Is Driven by Modulation of Gut Microbiota.

Authors:  Wenyan Ji; Ting Jiang; Zheng Sun; Fei Teng; Chenchen Ma; Shi Huang; Suhua Yan
Journal:  Front Pharmacol       Date:  2020-10-15       Impact factor: 5.810
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.